Keeley tapped to bring his biomedical engineering and technology commercialization background in leading new healthcare commercialization joint venture
May 25, 2021, Baltimore, MD – Early Charm, a venture studio that converts science to business, today announced the hiring of Dan Keeley to lead Lankenau Ventures, a new joint venture with Early Charm that aims to accelerate development and commercialization of medical inventions conceived by frontline healthcare workers.
The joint venture’s partners include Early Charm; the Lankenau Institute for Medical Research (LIMR), the research division of Main Line Health; and L2C Partners, an outsourced technology transfer and commercialization provider.
Keeley, a biomedical engineer and veteran technology commercialization expert, will lead Lankenau Ventures’ core objective to license inventions from LIMR that focus on the operating room, the hospital patient room and other healthcare venues. In commercializing those inventions, the qualities of safety, quality and efficacy will be matched with market demand to determine priorities for product development.
"We’ve worked with Dan on several projects over the years and are really impressed with his skill at commercializing products,” said Ken Malone, Executive Officer with Early Charm. "With Dan’s leadership, this important joint venture can begin its work of bringing to the market new technologies to improve the lives of patients.”
In his most recent position, Keeley was Business Strategist with Dawnbreaker, a Rochester, NY-based technology commercialization consulting firm with a focus on federal agencies' Small Business Innovation Research program grants.
Prior to this role, Keeley served as Director of Operations and Startup Development with the University of Rochester’s High Tech Rochester and Licensing Manager with UR Ventures.
In addition to his experience at the University of Rochester, Keeley brings an extensive background in engineering innovation and technology commercialization from the private sector. Keeley spent six years at Johnson & Johnson working in new product development and technical project management and later worked in Global Strategy at Becton Dickinson Biosciences.
Throughout his career, Keeley has established product roadmaps for dozens of technologies and managed all stages of new product development from inception through launch.
Keeley earned a BS in Biomedical Engineering; a M.Eng. in Biomedical Engineering; and a MBA with Cornell University.
About Lankenau Ventures:
Lankenau Ventures commercializes the inventions of front line healthcare workers from Main Line Health and the Lankenau Institute for Medical Research (LIMR). Lankenau Ventures was created by Early Charm, LIMR and L2C Partners. Lean more: www.lankenauventures.com
About Early Charm:
Early Charm creates, owns and operates businesses that convert science into revenue. We are the management team, the operators and the entrepreneurs. We don’t write checks and just pop in for board meetings. We show up to our labs, our production facilities and our offices every day to do all the heavy lifting in our portfolio companies. Learn more: www.earlycharm.com
Early Charm Ventures